StockData

Dyadic International vs Evogene

DYAI and EVGN side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DYAI and EVGN compare

Dyadic International grew revenue faster over the last twelve months (−7.6% versus −30.9% for Evogene).

Evogene keeps more of each dollar of sales as profit, with a net margin of −220% compared with −227% at Dyadic International.

Dyadic International scores higher on the StockData Score (7 against 3 for Evogene), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDYAIEVGN
Size and price
Market cap$11.7M–
Share price$0.320$0.392
Change, 1 year−64.6%−67.1%
Change, 5 years−91.4%−98.1%
Beta (5Y)1.441.91
Employees578
StockData Score
Total score7 (better)3
Valuation score1 (better)0
Growth score01 (better)
Performance score11
Health score5 (better)1
Dividend score00
Valuation
P/S3.8×–
Growth
Revenue growth (TTM)−7.6% (better)−30.9%
Revenue growth, 5Y average14.0%29.9% (better)
Profitability
Gross margin17.9% (better)−6.3%
Operating margin−237% (better)−364%
Net margin−227%−220% (better)
FCF margin–−354%
Return on equity−47256%–
Financial health
Interest coverage–−7.3×
Current ratio1.693.57 (better)
Altman Z-score−18.95–
Piotroski F-score23 (better)
Dividends and buybacks
Shareholder yield0.00%–
Ownership
Held by institutions12.7%3.2%
Held by insiders28.0%50.7%
Insider net buying, 12 months−$125K$695K (better)
Short interest, % of float0.32%1.6%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.